Cetuximab-Based Immunotherapy and Radioimmunotherapy of Head and Neck Squamous Cell Carcinoma | Zendy

Gang Niu | Zendy; Xilin Sun | Zendy; Qizhen Cao | Zendy; Donald Courter | Zendy; Albert C. Koong | Zendy; QuynhThu Le | Zendy; Sanjiv S. Gambhir | Zendy; Xiaohong Chen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cetuximab-Based Immunotherapy and Radioimmunotherapy of Head and Neck Squamous Cell Carcinoma

Author(s) -

Gang Niu,

Xilin Sun,

Qizhen Cao,

Donald Courter,

Albert C. Koong,

QuynhThu Le,

Sanjiv S. Gambhir,

Xiaohong Chen

Publication year - 2010

Publication title -

clinical cancer research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.427

H-Index - 324

eISSN - 1557-3265

pISSN - 1078-0432

DOI - 10.1158/1078-0432.ccr-09-2495

Subject(s) - cetuximab , head and neck squamous cell carcinoma , radioimmunotherapy , medicine , epidermal growth factor receptor , cancer research , immunotherapy , head and neck cancer , cancer , pathology , antibody , monoclonal antibody , colorectal cancer , immunology

To show the relationship between antibody delivery and therapeutic efficacy in head and neck cancers, in this study we evaluated the pharmacokinetics and pharmacodynamics of epidermal growth factor receptor (EGFR)-targeted immunotherapy and radioimmunotherapy by quantitative positron emission tomography (PET) imaging.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research